Article
A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.
American journal of physiology. Gastrointestinal and liver physiology - 1 Apr 2021
Moore Mary P, Cunningham Rory P, Davis Rachel A H, Deemer Sarah E, Roberts Brandon M, Plaisance Eric P, Rector R Scott
Abstract excerpt
Nutritional ketosis as a therapeutic tool has been extended to the treatment of metabolic diseases, including obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD). The purpose of this study was to determine whether dietary administration of the ketone ester (KE) R,S-1,3-butanediol diacetoacetate (BD-AcAc2) attenuates markers of hepatic stellate cell (HSC) activation and hepatic fibrosis in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
